Overview

Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0

Status:
Completed
Trial end date:
2019-06-25
Target enrollment:
Participant gender:
Summary
To treat an intermediate size patient population of bilateral lung transplant patients with CLAD-0.
Phase:
Phase 1
Details
Lead Sponsor:
Duke University
Treatments:
Ascorbic Acid